Skip to Content

Criticism of the Obama Administration’s Volt Report

Did the review of GM’s prospects depend on unrealistic assumptions about its plug-in technology?
April 16, 2009

A couple of weeks ago a report from President Obama’s Auto Task Force roundly criticized GM’s Volt plug-in hybrid–an electric car designed to travel 40 miles on battery power alone and hundreds of miles using a gasoline or ethanol-powered generator. Now some are claiming that the task force’s assessment of the Volt may have been based on some erroneous figures supplied by a consulting firm.

A company reportedly hired to help the Auto Task Force, Boston Consulting Group, has recently published a report that includes estimates of battery costs that are far higher than GM’s own cost estimates, as well as those from other analysts, according to Felix Kramer, the founder of CalCars, an organization that promotes plug-in hybrids. He writes:

The report reaches questionable conclusions about costs for plug-in vehicles based on elevated battery costs, which it sees currently at $2,000 per kilowatt-hour now, declining to $500-$700 by 2020. This assumption is the heart of its analysis – and it’s one that automakers, especially GM, have strongly criticized. While not getting specific, GM has made clear that its battery costs (for packs, not cells) will be “hundreds less” than $1,000 for the first generation Volt and still lower in the second and third generations of the Volt, on which it is already at work. GM isn’t waiting for the “breakthroughs in technology” BCG sees as necessary.

Read the rest of Kramer’s analysis here.

Keep Reading

Most Popular

Workers disinfect the street outside Shijiazhuang Railway Station
Workers disinfect the street outside Shijiazhuang Railway Station

Why China is still obsessed with disinfecting everything

Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

individual aging affects covid outcomes concept
individual aging affects covid outcomes concept

Anti-aging drugs are being tested as a way to treat covid

Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

Europe's AI Act concept
Europe's AI Act concept

A quick guide to the most important AI law you’ve never heard of

The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.